3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Disease
1
Colonic Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Interventions
Nivolumab
25
pembrolizumab
24
Specimen Handling
17
Ipilimumab
16
Magnetic Resonance Spectroscopy
12
Opdualag
7
CTLA-4 Antigen
7
Biopsy
6
trametinib
5
relatlimab
5
dabrafenib
4
binimetinib
4
Paclitaxel
4
Cyclophosphamide
4
fludarabine
3
capivasertib
3
atezolizumab
3
aldesleukin
3
Taxes
3
Standard of Care
3
Pemetrexed
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Carboplatin
3
Blood Specimen Collection
3
ulixertinib
2
tislelizumab
2
sargramostim
2
omipalisib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
No trials found.